Top Markets
Coin of the day
CardioGenics Holdings Inc CardioGenics Holdings Inc

CardioGenics Holdings Inc

CGNH
Hisse Senetlerindeki Sıralama #41819
CardioGenics Holdings Inc. focuses on the creation and global distribution of... CardioGenics Holdings Inc. focuses on the creation and global distribution of diagnostic testing solutions within the in vitro diagnostics (IVD) sector, serving markets across the United States, Canada, Europe, and other international regions. A key offering is the QL Care Analyzer, an automated, self-contained, and portable point-of-care (POC) immunoassay device. This analyzer utilizes a unique, patented self-metering cartridge to perform immunoassay evaluations directly at the point of care. The company also provides a range of immunoassay panels specifically engineered to detect cardiac biomarkers in blood, which is vital for identifying heart attacks. Additionally, CardioGenics supplies paramagnetic beads, serving as crucial solid supports in heterogeneous immunoassay procedures for both clinical and research institutions. Established in 1997, the company was initially known as Jag Media Holdings, Inc. before officially changing its name to CardioGenics Holdings Inc. in 2009. Its corporate headquarters are situated in Mississauga, Canada.
Hisse Fiyatı
$0.0001
Son senkronizasyon: 2026-08-11
Piyasa Değeri
$9.61K
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
CA
Ticaret CardioGenics Holdings Inc (CGNH)

Kategori

CardioGenics Holdings Inc (CGNH) için kazanç
2026 itibarıyla kazanç TTM: 0
CardioGenics Holdings Inc şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
CardioGenics Holdings Inc için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$7.61B -
US
$4.76B -
US
- -
CN
$1.42B -
US
$-252.70M -
US